The global regenerative medicines
market is forecasted to reach the market value of $1.4 billion over the
year 2015 powered by increasing focus on stem cell research, aging baby
boomers, greater usage of non-autograft products, and increasing
investments in research and development activities.
Regenerative medicine industry is
assumed to be the next generation technology to revolutionize the
medical system in the upcoming years. This industry is still in growing
stage in terms of commercial applications, with a number of available
products being limited to the field of orthopedics. A majority of
products in other therapeutic fields are in preclinical or early
clinical assessment stage. Support from governments around the world and
technological breakthroughs are expected to drive the market growth for
the regenerative medicines industry.
Aging population with various age
related cell dysfunctions provide a ready market for new therapies based
on tissue engineering and regenerative medicines. Advancements in
biological sciences are drastically impacting the regenerative medicine
market in a positive way. Growing awareness about the use of
regenerative medicines and increasing usage of non-autograft products is
stimulating the growth of this market. Also, rising investments in
research and development activity and improvements in regenerative
equipments is further propelling the growth of this market.
Read More: Regenerative Medicines Market
Market Segmentation
- Tissue Engineering
- Stem Cell Therapy
- Nanoscience
- Bioengineering
Application Segments
- Cardiovascular Diseases
- Diabetes
- Cancer
- CNS Diseases
- Eye Diseases
Regenerative medicines market analyzes
this market depending on its segments and major geographies.
Geographies analyzed under this research report are
- North America
- Asia Pacific
- Europe
- Rest of the World
This report includes comprehensive analysis of
- Current market trends
- Industry growth drivers
- Restraints
- Market structure
- Market projections for the near future
This report also includes detailed
analysis of technological improvements in the field, Porter’s five force
model analysis, and complete company profiles of top industry players.
The report provides review of micro
and macro factors significant with respect to new entrants and existing
market players with value chain analysis.
Major Players
Some of the major players dominating
this market are Aastrom Biosciences Inc., Advanced Cell Technology Inc.,
Athersys Inc, Amgen Inc., Bioheart Inc., Cytori Therapeutics Inc.,
Celgene Corporation, Geron Corporation, Genzyme Corporation, Osiris
Therapeutics, Japan Tissue Engineering Co. Ltd., ThermoGenesis
Corporation, and others.
Reasons for Buying this Report
- Report provides technological growth map over time and explains its impact on market
- It helps in making informed business decisions by making in-depth analysis of market
- It provides distinctive graphics and exemplified SWOT analysis of major industry segments
- It also provides up-to-date analysis of latest trends in market and helps you stay updated with recent technological improvements
- It provides clear understanding of changing competitive dynamics and keeps you ahead of competitors
- This research report provides overview of major market forces driving and restraining market growth
- Report provides detailed analysis of major competitors and their strategies.
http://www.transparencymarketresearch.com/regenerative-medicines-market.html
0 comments:
Post a Comment